One of the problems Oprah brought up involved a bone marrow
transplant. Stewart Eastham, a 25 year old worker in the oil and gas
industry, was told by the hospital that he must bring $250,000 cash
for a life saving treatment. Stewart's insurance would only cover
$150,000 of the procedure, and he needed to pay the additional
$250,000.
The delay in his treatment caused Stewart to go blind in one eye.
Lisa
Ling decided to call his insurance company to find out what had
happened with Stewarts case. She wanted to talk to the CEO of Blue
Cross / Blue Shield about his case. <<

Jeez .. he should have been reading the .. groups .. he might have
found a .. cure.

<<snip>>
resulting in long-lasting transfusion-free survival
<<snip>>

Correction of anemia in a transfusion-dependent patient with primary
myelofibrosis receiving iron chelation therapy with deferasirox
(Exjade®, ICL670)
Authors: Di Tucci, Anna Angela1; Murru, Roberta1; Alberti, Daniele2;
Rabault, Bertrand2; Deplano, Simona1; Angelucci, Emanuele1

Source: European Journal of Haematology, Volume 78, Number 6, June
2007, pp. 540-542(3)

Publisher: Blackwell Publishing
Abstract:

Transfusional iron overload in patients with chronic anemias can
result in multiple organ failure. Experience in the management of
iron
overload in patients with myelodysplastic syndromes is limited, as
many do not receive chelation therapy due to short-life expectancy
and
the difficulties associated with the administration of the current
reference standard chelator, deferoxamine. There have, however, been
some reports of reduced transfusion requirement associated with
chelation therapy in patients with myelodysplastic syndromes and
myelofibrosis. Here, we discuss a patient with primary myelofibrosis
and related transfusion-dependent anemia who received chelation
therapy with the once-daily oral iron chelator, deferasirox. In
addition to the reduced iron levels, the patient demonstrated an
unexpected reduction in blood transfusion requirement, ultimately
resulting in long-lasting transfusion-free survival.
Keywords: myelofibrosis; iron overload; chelation

Document Type: Research article

DOI: 10.1111/j.1600-0609.2007.00840.x

Affiliations: 1: Unità Operativa Ematologia e Centro Trapianti
Midollo
Osseo, Ospedale Oncologico `Armando Businco', Cagliari, Italy 2:
Novartis Pharma AG, Basel, Switzerland

Who loves ya.
Tom

Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com

Man Is A Herbivore!
http://tinyurl.com/a3cc3

DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk